2012

Infliximab in postoperative recurrence in CD

Adalimumab in paediatric CD

Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn’s Disease

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Mesalazine in UC once or twice daily

Profermin is efficacious in patients with active ulcerative colitis–a randomized controlled trial

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn’s Disease

Secukinumab in mode-severe CD

Infliximab stop in CD

Infliximab switch to adalimumab in CD

Tacrolimus in steroid dependent UC